Skip to content

H2020

PREMIER

Prioritisation and Risk Evaluation of Medicines in the EnviRonment

Programme
Horizon 2020
Started
Ends
Duration
72 months
Total cost
EUR 10,904,030
EU contribution
EUR 4,550,000
Participants
26 from 11 countries
Topic
H2020_IMI2-2019-17-03
Grant agreement
875508

Coordinated by Stichting Radboud Universiteit (NLNetherlands).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Stichting Radboud UniversiteitNLNetherlandsCoordinatorEUR 725,309known name (0.95)
Janssen Pharmaceutica NVBEBelgiumParticipantEUR 0PIC (1.00)
Eidgenoessische Anstalt Fuer Wasserversorgung Abwasserreinigung und GewaesserschutzCHSwitzerlandParticipantEUR 296,498PIC (1.00)
Gsk Consumer Healthcare SarlCHSwitzerlandParticipantEUR 0PIC (1.00)
Novartis Pharma AGCHSwitzerlandParticipantEUR 0PIC (1.00)
Bayer AktiengesellschaftDEGermanyParticipantEUR 0PIC (1.00)
Ecologic Institut Gemeinnutzige GmbHDEGermanyParticipantEUR 172,586PIC (1.00)
Ect Oekotoxikologie GmbHDEGermanyParticipantEUR 363,498PIC (1.00)
Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschung EvDEGermanyParticipantEUR 254,244known name (0.95)
Leuphana Universitat LuneburgDEGermanyParticipantEUR 199,500PIC (1.00)
Teamit Research SLESSpainParticipantEUR 326,875PIC (1.00)
Helsingin YliopistoFIFinlandParticipantEUR 312,141known name (0.95)
Institut de Recherches Internationales ServierFRFranceParticipantEUR 0PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantEUR 0PIC (1.00)
Eli Lilly and Company LtdGBUnited KingdomParticipantEUR 0PIC (1.00)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Reckitt Benckiser LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
The University of ExeterGBUnited KingdomParticipantEUR 314,776PIC (1.00)
University of YorkGBUnited KingdomParticipantEUR 384,836known name (0.95)
Istituto di Ricerche Farmacologiche Mario NegriITItalyParticipantEUR 503,577PIC (1.00)
Rijksinstituut Voor Volksgezondheid en MilieuNLNetherlandsParticipantEUR 288,385known name (0.95)
The European Medicines AgencyNLNetherlandsParticipantEUR 47,000PIC (1.00)
Astrazeneca ABSESwedenParticipantEUR 0PIC (1.00)
Goeteborgs UniversitetSESwedenParticipantEUR 226,250PIC (1.00)
Bristol-Myers Squibb Company CorpUSUnited StatesParticipantEUR 0PIC (1.00)
Merck Sharp & Dohme CorpUSUnited StatesParticipantEUR 0PIC (1.00)

Changes of the consortium

First seen on with 26 participants from 11 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.